Syros Pharmaceuticals Statistics
Total Valuation
SYRS has a market cap or net worth of $7.35 million. The enterprise value is $9.73 million.
Important Dates
The last earnings date was Thursday, October 31, 2024, before market open.
Earnings Date | Oct 31, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SYRS has 26.81 million shares outstanding. The number of shares has increased by 31.77% in one year.
Current Share Class | 26.81M |
Shares Outstanding | 26.81M |
Shares Change (YoY) | +31.77% |
Shares Change (QoQ) | +0.17% |
Owned by Insiders (%) | 2.61% |
Owned by Institutions (%) | 33.68% |
Float | 13.07M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 27.64 |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 25.20 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.25
Current Ratio | 2.25 |
Quick Ratio | 2.05 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -20.92 |
Financial Efficiency
Return on equity (ROE) is -776.96% and return on invested capital (ROIC) is -94.28%.
Return on Equity (ROE) | -776.96% |
Return on Assets (ROA) | -59.88% |
Return on Capital (ROIC) | -94.28% |
Revenue Per Employee | $5,676 |
Profits Per Employee | -$1.44M |
Employee Count | 68 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.33% in the last 52 weeks. The beta is 1.59, so SYRS's price volatility has been higher than the market average.
Beta (5Y) | 1.59 |
52-Week Price Change | -90.33% |
50-Day Moving Average | 1.89 |
200-Day Moving Average | 4.35 |
Relative Strength Index (RSI) | 28.83 |
Average Volume (20 Days) | 23,817,879 |
Short Selling Information
The latest short interest is 1.25 million, so 4.66% of the outstanding shares have been sold short.
Short Interest | 1.25M |
Short Previous Month | 952,604 |
Short % of Shares Out | 4.66% |
Short % of Float | 9.55% |
Short Ratio (days to cover) | 3.20 |
Income Statement
In the last 12 months, SYRS had revenue of $386,000 and -$97.82 million in losses. Loss per share was -$2.66.
Revenue | 386,000 |
Gross Profit | -88.25M |
Operating Income | -111.52M |
Pretax Income | -131.56M |
Net Income | -97.82M |
EBITDA | -110.18M |
EBIT | -111.52M |
Loss Per Share | -$2.66 |
Full Income Statement Balance Sheet
The company has $58.28 million in cash and $60.23 million in debt, giving a net cash position of -$1.95 million or -$0.07 per share.
Cash & Cash Equivalents | 58.28M |
Total Debt | 60.23M |
Net Cash | -1.95M |
Net Cash Per Share | -$0.07 |
Equity (Book Value) | -11.12M |
Book Value Per Share | -0.41 |
Working Capital | 35.54M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$100.02 million and capital expenditures -$38,000, giving a free cash flow of -$100.05 million.
Operating Cash Flow | -100.02M |
Capital Expenditures | -38,000 |
Free Cash Flow | -100.05M |
FCF Per Share | -$3.73 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -28,891.71% |
Pretax Margin | -25,340.67% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -2,640.74% |
Dividends & Yields
SYRS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -31.77% |
Shareholder Yield | -31.77% |
Earnings Yield | -1,258.10% |
FCF Yield | -1,286.90% |
Analyst Forecast
The average price target for SYRS is $3.00, which is 993.69% higher than the current price. The consensus rating is "Hold".
Price Target | $3.00 |
Price Target Difference | 993.69% |
Analyst Consensus | Hold |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | 122.94% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on September 19, 2022. It was a reverse split with a ratio of 0.1:1.
Last Split Date | Sep 19, 2022 |
Split Type | Reverse |
Split Ratio | 0.1:1 |
Scores
SYRS has an Altman Z-Score of -15.52. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -15.52 |
Piotroski F-Score | n/a |